spacer
home > epc > winter 2003 > avoiding the pitfalls when completing a crf
PUBLICATIONS
European Pharmaceutical Contractor

Avoiding the Pitfalls when Completing a CRF

In the world of clinical trials, the concept of a CRF is a well-known phenomenon. According to ICH Topic E6, a CRF is "a printed, optical or electronic document designed to record all the protocol requirements to be reported to the sponsor on each trial subject". This definition implies the importance of completing a CRF correctly, as incorrect completion will lead to a misrepresentation of the data of a clinical study, since it is the means of complete data gathering during the trial.

Data collected in a CRF normally include data on the subject/patient, (including demographic and medical history), study drug admission (such as time, dose and method of administration), and the outcome of assessments as described in the protocol and full safety monitoring (adverse events, their seriousness, countermeasures and relationship to drug, for instance). It is of prime importance that these forms be completed correctly as to reflect a true picture of the trial procedures and findings.

Although the CRF is only completed during the clinical trial, its inception is much earlier. Shortly after protocol design, the CRF is drafted and finalised following protocol approval and permission to perform the trial. It can not be stressed enough that when a CRF is being designed, careful attention should be paid to the way provision is made for data capture during the clinical phase. If a CRF is well-designed and its instructions are user-friendly in layout, the correct completion of this important document is effortless and already, many potential errors can be averted.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Cornea Venter, Senior Data Manager, Biometry Division, and Daleen Krige, Medical Writer, Biometry Division, at FARMOVS-PAREXEL

Cornea Venter joined FARMOVS-PAREXEL in 1996 as a Statistical Programmer in the Biometry Division. In 1999 she accepted the position of Data Manager and was promoted to Senior Data Manager in 2001. She holds an Honours degree in Computer Science and has attended several conferences and workshops.


Daleen Krige joined FARMOVS-PAREXEL in 1995 as a Medical Writer in the Biometry Division, after teaching at several education institutions. She holds a Masters degree in Communication Science and is presently researching for a PhD. She attended two European Medical Writers Association (EMWA) conferences in 1996 and 2000.

spacer
Cornea Venter
spacer
spacer
spacer
Daleen Krige
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Pharmaceutical Packaging and Labelling Summit in Zurich; ACG presentation

At next week’s Pharmaceutical Packaging and Labelling Summit in Zurich (18-19 June), Dr. Eugen Hertel from ACG will be speaking on: Challenges for Global Pharma companies to Implement Anti-Counterfeit Strategy for Russian Track & Trace Regulation. This presentation will include details around ‘the fight against counterfeit medicine - there have been and still are worldwide initiatives to make the supply chain and the safety of medicines secure. After large markets such as the USA and Europe passed their laws and regulations for the pharmaceutical manufacturing companies and established the IT infrastructure, Russia is now next on the move.
More info >>

White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement